Efficacy and Safety Study of QVA149 in COPD Patients
Public ClinicalTrials.gov record NCT02487446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that the efficacy of the combination product QVA149 is similar to the efficacy of the combination product umeclidinium/vilanterol on a pre-specified endpoint of FEV1 AUC0-24h while maintaining an acceptable safety profile.
Study identification
- NCT ID
- NCT02487446
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 357 participants
Conditions and interventions
Conditions
Interventions
- QVA149 Drug
- Umeclidinium/vilanterol Drug
- Placebo (umeclidinium/vilanterol) Drug
- Placebo (QVA149) Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 28, 2015 (Actual)
- Primary completion
- Sep 12, 2016 (Actual)
- Completion
- Sep 12, 2016 (Actual)
- Last update posted
- Dec 26, 2017
2015 – 2016
United States locations
- U.S. sites
- 58
- U.S. states
- 21
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Andalusia | Alabama | 36305 | — |
| Novartis Investigative Site | Anniston | Alabama | 36207-5710 | — |
| Novartis Investigative Site | Jasper | Alabama | 35501 | — |
| Novartis Investigative Site | Multiple Locations | Alabama | — | — |
| Novartis Investigative Site | Multiple Locations | Arizona | — | — |
| Novartis Investigative Site | Tempe | Arizona | 85283 | — |
| Novartis Investigative Site | Tucson | Arizona | 85723 | — |
| Novartis Investigative Site | Fayetteville | Arkansas | 72703 | — |
| Novartis Investigative Site | Huntington Beach | California | 92647 | — |
| Novartis Investigative Site | Rancho Mirage | California | 92270 | — |
| Novartis Investigative Site | Colorado Springs | Colorado | 80907 | — |
| Novartis Investigative Site | Altamonte Springs | Florida | 32701 | — |
| Novartis Investigative Site | DeLand | Florida | 32720 | — |
| Novartis Investigative Site | Fort Lauderdale | Florida | 33316-192 | — |
| Novartis Investigative Site | Kissimmee | Florida | 34741 | — |
| Novartis Investigative Site | Miami | Florida | 33172 | — |
| Novartis Investigative Site | Pensacola | Florida | 32503 | — |
| Novartis Investigative Site | Pensacola | Florida | 32504 | — |
| Novartis Investigative Site | Port Orange | Florida | 32127 | — |
| Novartis Investigative Site | Conyers | Georgia | 30094 | — |
| Novartis Investigative Site | Duluth | Georgia | 30096 | — |
| Novartis Investigative Site | Meridian | Idaho | 83642 | — |
| Novartis Investigative Site | New Orleans | Louisiana | 70119 | — |
| Novartis Investigative Site | Slidell | Louisiana | 70458 | — |
| Novartis Investigative Site | Sunset | Louisiana | 70584 | — |
| Novartis Investigative Site | Columbia | Maryland | 21044 | — |
| Novartis Investigative Site | Edina | Minnesota | 55435 | — |
| Novartis Investigative Site | Fridley | Minnesota | 55432 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55402 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55407 | — |
| Novartis Investigative Site | Plymouth | Minnesota | 55441 | — |
| Novartis Investigative Site | Henderson | Nevada | 89014 | — |
| Novartis Investigative Site | New York | New York | 10016 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Cornelius | North Carolina | 28031 | — |
| Novartis Investigative Site | Gastonia | North Carolina | 28054 | — |
| Novartis Investigative Site | Hickory | North Carolina | 28602 | — |
| Novartis Investigative Site | High Point | North Carolina | 27262 | — |
| Novartis Investigative Site | Huntersville | North Carolina | 28078 | — |
| Novartis Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45242 | — |
| Novartis Investigative Site | Columbus | Ohio | 43213 | — |
| Novartis Investigative Site | Columbus | Ohio | 43215 | — |
| Novartis Investigative Site | Dublin | Ohio | 43016 | — |
| Novartis Investigative Site | Marion | Ohio | 43302 | — |
| Novartis Investigative Site | Medford | Oregon | 97504 | — |
| Novartis Investigative Site | Portland | Oregon | 97213 | — |
| Novartis Investigative Site | Philadelphia | Pennsylvania | 19142 | — |
| Novartis Investigative Site | Tipton | Pennsylvania | 16684 | — |
| Novartis Investigative Site | Carrollton | Texas | 75010 | — |
| Novartis Investigative Site | Channelview | Texas | 77530 | — |
| Novartis Investigative Site | Fort Worth | Texas | 76109 | — |
| Novartis Investigative Site | Lampasas | Texas | 76550 | — |
| Novartis Investigative Site | McKinney | Texas | 75069 | — |
| Novartis Investigative Site | New Braunfels | Texas | 78130 | — |
| Novartis Investigative Site | Salt Lake City | Utah | 84102 | — |
| Novartis Investigative Site | Newport News | Virginia | 23606 | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02487446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 26, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02487446 live on ClinicalTrials.gov.